Diagnosis of Renal Cell Carcinoma on 68Ga-PSMA PET-CT and Radioligand Therapy With 177Lu-EB-PSMA-617
NCT05170555
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
40
Enrollment
OTHER
Sponsor class
Conditions
Renal Cell Carcinoma
Interventions
DRUG:
68Ga-PSMA
DRUG:
1.85GBq (50 mCi) of 177Lu-EB-PSMA-617
Sponsor
Peking Union Medical College Hospital